To Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia

Recruiting

Phase 3

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia

Sponsor:

89bio, Inc.

Code:

NCT05852431

Conditions

Severe Hypertriglyceridemia

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information